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AB S T R A C T  
The disease preventive and health promoting approach based on herbal medicine 
takes into consideration, the promotion of health and treating ailments is holistic way 
and finds increasing acceptability in many regions of the world, India and China being 
in the forefront. The practice of herbal medicine basically depends on folklore and by 
experiences of people over a long period of time. However, very little research 
especially in the area of basic science has been conducted in a systematic manner. 
Medicinal plants with a long history of safe and effective use are likely to have a 
pharmaceutical effect. The use of plants in traditional medicine can be explained by 
physiologically active phytochemical compounds of a species and also by its ascribed 
meaning in a culture.  Plants produce a great diversity of substances that could be of 
therapeutic significance in many areas of medicine. However, the chemical nature of 
plant compounds present naturally as such and in extract, is puzzling. It is important 
to know constituents of plant extracts and their relative importance in their 
therapeutic value. The alkaloids and other compounds are characterized and tested 
for their medicinal value from these plants which include not only the unexplored 
tribal plants but also the spices, condiments and vegetables which are already in use. 
In last decade, there is a renewed interest in the development of herbal drugs 
underlined by the understanding of mechanism of action rather than based on faith 
and folk, as it happened in past. Several aspects on integrated approaches of drug 
development from herbs have explored many potential lead phytochemicals. 
Nonetheless, even the limited number of mechanistic experiments reveals that 
numerous mechanisms are likely involved in the various actions of even a single 
herbal medicine. It will be the elucidation of such mechanisms that will provide the 
scientific basis for establishing the efficacy and safety of not only Chinese and Indian 




Plants are providing humankind with all needs including 
food, clothing, shelter, flavours and fragrances as not the least, 
medicines. Plants form the basis of traditional medicine, 
Ayurvedic, Unani, Chinese amongst others. Medicinal plants 
have been used throughout the world, however, their wide usage 
had been limited to China, India, Japan, Pakistan, Sri Lanka, 
Thailand and African countries. Developed countries are also 
turning to encourage the usage of plant-based natural medicinal 
product in their healthcare systems. World Health Organisation 
estimates that 80% of the world’s inhabitants rely mainly on 
traditional medicines for their health care (Farnsworth, 1994; 
Mukherjee and Wahil, 2006). Plant products also play an 
important role in health care systems of the remaining 20% of the 
population, mainly residing in developed countries. The Natural 
Health Product Regulations of Canada promulgated in January 
2004 is an important step toward modernization of plant-based 
product usage in healthcare (Siow et al., 2005). This regulation 
encourages usage of modern technology and evidence-based 
scientific support toward promoting medicinal plants and the 
associated products. With the advancement of Ayurvedic 
tradition and its scientific exploration, several classes of plant 
species have been studied in order to evaluate their therapeutic 
potentials and to isolate the lead compounds. 
 
 
Folk medicine in India 
Folk medicine is the mother of the healing systems of 
India (Valiathan, 2006). It is universally accepted now that 
traditional health care systems have their unique strengths and 
are worth exploring for their potential preventive and curative 
properties. Herbal remedies are considered the oldest forms of 
healthcare known to mankind on this earth. Prior to the 
development of modern medicine, the traditional systems of 
medicine that have evolved over the centuries within various 
communities, are still maintained as a great traditional 
knowledge base. Traditionally, this treasure of knowledge has 
been passed on orally from generation to generation without any 
written document (Perumal Samy and Ignacimuthu, 1998, 2000), 
and is still retained by various indigenous groups around the 
world. In India, there are about 54 million indigenous people of 
different ethnic groups inhabiting various terrains. These 
indigenous groups possess their own distinct culture, religious 
rites, food habit and a rich knowledge of traditional medicine 
(John, 1984; Pushpangadan and Atal, 1984; Anuradha et al., 
1986; Harsha et al., 2002; Parinitha et al., 2005). Even today, 
indigenous and certain local communities practice herbal 
medicine to cure a variety of diseases. Traditional system of 
medi-care is still practised by the people of rural areas as they 
are safe, no adverse effects, inexpensive and ease availability. 
However, a gradual decline in practice of traditional herbal 
medicines has been reported in the recent past. Hence, there is 
an urgent need to investigate in detail the indigenous 
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ethnobotanical knowledge held by each tribal people before such 
valuable knowledge disappears. Further, it is also necessary to 




There are more than 20,000 species of higher plant, used 
in traditional medicines and are reservoirs of potential new 
drugs. As the modern medicine and drug research advanced, 
chemically synthesized drugs replaced plants as the source of 
most medicinal agents in industrialized countries. Nevertheless 
plants are an important source of lead compounds. However, in 
developing countries, the majority of the world’s population 
cannot afford pharmaceutical drugs and use their own plant 
based indigenous medicines. In recent times, focus on plant 
research has increased all over the world, and a large body of 
evidence has been collected to show the immense potential of 
medicinal plants used in traditional systems. Various medicinal 
plants have been identified and studied using modern scientific 
approaches. The results revealed the potential of medicinal 
plants in the field of pharmacology (Tapsell et al., 2006; Triggiani 
et al., 2006). 
The use of plants in traditional medicine can be 
explained by physiologically active phytochemical compounds of a 
species and also by its ascribed meaning in a culture. Medicinal 
plants with a long history of safe and effective use are likely to 
have a pharmaceutical effect (Tabuti, 2008). In addition, the 
likeliness of a medicinal use being based on pharmaceutical 
properties rather than on a cultural context increases when this 
use is repeatedly found in different cultures. 
According to Gurib-Fakim (2006) there are four basic 
ways in which plants that are used by tribal peoples are valuable 
for modern medicine: 1. Plants used as sources of direct 
therapeutic agents  2. Plants are also used as sources of starting 
points for the elaboration of semi-synthetic compounds  3. Plants 
can serve as sources of substances that can be used as models for 
new synthetic compounds. 4. Plants can also be used as 
taxanomic markers for the discovery of new compounds.  
 
Recently explored medicinal plants - examples 
Many plants have a long use in traditional Ayurvedic 
medicine for several diseases and the scientific studies are 
reconfirming them with modern relevance.  The scientific basis 
for the statement that plants and their active constituents play 
an important role in the prevention of chronic and degenerative 
diseases is continuously advancing. In fact, the origin of many 
therapeutic substances is due to secondary metabolism in the 
plants. 
A wide range of secondary metabolites including 
triterpenoids, flavonol glycosides, anthocyanins and steroids has 
been isolated from Clitoria ternatea Linn. Its extracts possess a 
wide range of pharmacological activities including antimicrobial, 
antipyretic, anti-inflammatory, analgesic, diuretic, local 
anesthetic, antidiabetic, insecticidal, blood platelet aggregation-
inhibiting and for use as a vascular smooth muscle relaxing 
properties (Mukherjee et al., 2008). 
Samy et al. (2008) in a survey among medicinal 
practitioners called ‘Vaidyars’ in Tamil Nadu identified 72 
medicinal plants belonging to 53 families that are used for the 
treatment of snakebite in a traditional way. They also report the 
partially purified extracts of Aristolochia indica, Hemidesmus 
indicus, Gloriosa superba, Strychnos nux-vomica, Eclipta 
prostrata, and Andrographis paniculata showing potent 
neutralizing effect against the snake venom both in vitro and in 
vivo.  
Recently, effect of several new plants of Arunachal 
Pradesh viz.,  Bombax ceiba, Canarium strictum, Chloranthus 
erectus, Xanthium indicum, Lycopodium clavatum, Coleus 
blumei, Batrachospermum atrum, Chlorella vulgaris, Marchantia 
palmata, Marchantia polymorpha, Eria pannea, Sterculia villosa 
and Alpinia galanga are reported for the first time for the 
treatment of inflammation-related diseases (Namsa et al., 2009). 
Cassia occidentalis is an annual or perennial Ayurvedic 
plant which is used in several traditional medicines to cure 
various diseases. This weed has been known to possess 
antibacterial, antifungal, antidiabetic, anti-inflammatory, 
anticancerous, antimutagenic and hepatoprotective activity. A 
wide range of chemical compounds including achrosin, 
aloeemodin, emodin, anthraquinones, anthrones, apigenin, 
aurantiobtusin, campesterol, cassiollin, chryso-obtusin, 
chrysophanic acid, chrysarobin, chrysophanol, chrysoeriol etc. 
have been isolated from this plant (Yadav et al., 2010). 
Psidium guajava, is an important food crop and 
medicinal plant in tropical and subtropical countries is widely 
used like food and in folk medicine around of the world. Different 
pharmacological experiments in a number of in vitro and in vivo 
models have been carried out. A number of metabolites phenolic, 
flavonoid, carotenoid, terpenoid and triterpene particularly those 
from leaves and fruits possess useful pharmacological activities. 
Many pharmacological studies have demonstrated the ability of 
this plant to exhibit antioxidant, hepatoprotection, anti-allergy, 
antimicrobial, antigenotoxic, antiplasmodial, cytotoxic, 
antispasmodic, cardioactive, anticough, antidiabetic, 
antiinflamatory and antinociceptive activities, supporting its 
traditional uses (Guti´errez et al., 2008). 
Albizia lebbeck is reported to possess considerable 
potency in anti-inflammatory action and has prominent effects on 
adjuvant arthritis by alleviating paw edema (Babu et al., 2009). 
The mechanism of the effect may be due to the presence of 
flavanoids and saponins, however, further detailed studies will 
provide new insight into the anti-inflammatory activity of Albizia 
lebbeck, and eventually lead to development of a new class of 
anti-inflammatory agent. 
Many pharmacological studies have been carried out to 
describe multiple biological properties of Withania somnifera 
(Mishra et al., 2000). These studies have shown that the plant 
preparation has antiinflammatory (Bhattacharya et al., 1997), 
anticancer (Mohan et al., 2004), antistress and 
immunomodulatory (Archana and Namasivayam, 1999; Ziauddin 
et al., 1996), adaptogenic (Bhattacharya and Muruganandam, 
2003), central nervous system (Chaudhary et al., 2003; Jain et 
al., 2001), endocrine (Panda and Kar, 1998) and cardiovascular 
(Mishra et al., 2000; Mohanty et al., 2004) activities, respectively. 
The major biochemical constituents of W. somnifera are 
steroidal alkaloids and lactones, a class of constituents together 
known as withanolides (steroidal lactones with ergostane 
skeleton) (Elsakka et al., 1990). So far 12 alkaloids, 35 
withanoloids and several sitoindosides have been isolated and 
their structures have been elucidated (Mishra et al., 2000; 
Matsuda et al., 2001). The various alkaloids include withanine, 
somniferine, somnine, somniferinine, withananine, psuedo-
withanine, tropine, psuedotropine, 3-α-gloyloxytropane, choline, 
cuscohygrine, isopelletierine, anaferine and anahydrine. 
The genus Hibiscus contains 220 species distributed 
around the world. It is an interesting source of potential bioactive 
molecules, as phenolic compounds, triterpene derivatives, 
phytosteroids, with antioxidant, cardioprotective, 
antihypertensive and antiproliferative activities (Maganha et al., 
2010). Pharmacological investigations of the genus Hibiscus 
indicated the presence of some species with useful biological 
activities as antihypertensive, anti-inflammatory, antipyretic, 
hepatoprotective, anti-diarrhoeic, anti-spermatogenic, anti-
tumour, antidiabetic, anticonvulsivant, antihelminthic 
immunomodulator, antioxidant and antimutagenic agents 
(Sachdewa and Khemani, 2003). Amongst these species, less than 
15 have had their biological effects studied. The majority of these 
studies mainly concentrated on Hibiscus sabdariffa. 
Euphorbia fusiformis a dwarf perennial herb, grows wild 
in western peninsular India and warmer parts of eastern India. 
The plant is of recent discovery from Tamil Nadu (John Britto et 
al., 2002). The dried root powder and fresh rhizome have been 
found to increase secretion of mother’s milk. Extract of dried 
rhizome is also administrated orally for relief from joint pain and 
rheumatism and it is more effective against diarrhea. Fresh latex 
is externally applied to heal chronic wounds and cracks and to 
cure skin diseases. Crushed leaf poultice is applied on forehead to 
get relief from acute headache. The earlier pharmacological 
studies have reported that this species possess effective anti-
inflammatory (Singh et al., 1984) and antimicrobial (Natarajan et 
al., 2005) properties. Recently, Anusuya et al. (2010) justified the 
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traditional claims and assessed the hepatoprotective effect of 
Euphorbia fusiformis tubers employing rifampicin intoxicated rat 
model and also assessed its safety upon administration. 
The use of different parts of Ricinus cummunis for the 
treatment of various diseases in traditional or folk remedies 
throughout the world has been reported. In the Indian system of 
medicine, the leaf, root and seed oil of this plant have been used 
for the treatment of inflammation and liver disorders as they 
have been found to be hepatoprotective (Visen et al., 1992), 
laxative (Capasso et al., 1994) and diuretic (Abraham et al., 
1986). The antifertility activity of 50% ethanolic extract of R. 
communis has also been reported (Sandhyakumary et al., 2003). 
Shokeen et al. (2008) reported the antidiabetic activity of 50% 
ethanolic extracts and purified fractions of R. cummunis. 
Since a long time, medicinal plants have been used for 
the treatment of many infectious diseases without any scientific 
evidence. At present there is more emphasis on determining the 
scientific evidence and rationalization of the use of these 
preparations. Research is in progress to identify plants and their 
active principles possessing activity against sexually transmitted 
pathogens including human immunodeficiency virus (HIV) with 
an objective of providing an effective approach for prevention of 
transmission and treatment of these diseases (Mukhtar et al., 
2008). 
In VIT University, characterization and testing of herbal 
extracts and their purified form are under meticulous 
investigation. Anticancer properties of plants like Oroxylum 
indicum, Acacia nilotica, Bacopa monneirei, Picrorhiza kurroa 
was studied using cancer cell lines. Methanolic and aqueous 
extracts of O. indicum was found to exhibit cytotoxic effect to 
cancer cell lines. The aqueous extract with its antioxidant 
activity exhibited DNA protection against free radical damage. 
Costus pictus which is popularly called as ‘insulin plant’ was 
investigated for its antidiabetic and antioxidant properties. 
Experiments on liver and kidney cells of diabetic rats indicated 
that this plant extracts do not have any cytotoxic effect in normal 
and cancer cells. The inhibitory activity on carbohydrate 
hydrolyzing enzyme might be attributed to the mode of action of 
this plant extract. In yet another study, the extracts of triphala 
was found to have anti-arthritic, analgesic effect, anti-pyretic 
action and anti-ulcerogenic activity. Acacia nilotica, Curcuma 
longa and Lawsonia inermis showed antioxidant activity which 
validates their potential role in alleviating cancer. Costus pictus, 
the insulin plant, showed significant reduction in FPG level of 
STZ induced diabetic rat and significant reduction in serum and 
organ lipid level suggesting the hypolipidimic activity of this 
plant. Significant effect on TNF-alpha production, humoral 
antibodies, lymphocyte proliferation and delayed type 
hypersensitivity were observed in arthritis rats administered 
with extract from Triphala, indicating the immune-modulatory 
function of this plant. Administration of triphala extract in 
animal models proved to be efficacious, specific and non toxic and 
hence warrants further investigation, before development of drug 
formulations. 
 
Formulations and Testing 
Testing the biological activity of medicinal or potentially 
medicinal plant materials demands a special approach. 
Investigations may be focused on understanding the bioactivity 
or a compounded plant extract or simply directed at isolating a 
single bioactive chemical compound. In the latter case, results 
often lead to oversimplification or wrong explanations or the 
bioactivity or extract preparations. On the other hand, thorough 
studies on single bioactive constituents provide important 
information for plant drug research. However, the much more 
complex array of molecular interactions and bioactivity 
mechanisms that arises from plant extracts represents a much 
greater and more fascinating challenge to science. Reverse 
pharmacology and herbal drug formulation The traditional 
knowledge-inspired reverse pharmacology described here relates 
to reversing the routine ‘laboratory-to-clinic’ progress to ‘clinics-
to-laboratories’. Patwardhan and Meshelkar (2009) suggest that 
drug discovery need not be always confined to the discovery of a 
single molecule. Many analysts believe that the current ‘one drug 
fits all’ approach may be unsustainable in the future. The 
growing interest in polypill concept is indicative of the need to 
collectively address multiple targets, risk factors or symptoms. 
The FDA and a few other agencies have come up with 
practical guidelines for botanical ‘drug’ development. A botanical 
drug product often has unique features and may include complex 
mixtures with as yet unknown active ingredients. No botanical 
products are, however, currently approved or marketed as 
prescription drugs. The FDA recognizes that prior human 
experience with botanical products may be documented in many 
different forms and sources, some of which may not meet the 
quality standards of modern scientific testing. The FDA, 
maintains, however, the same standards for safety and efficacy 
for marketing approval whether it is a botanical-sourced product 
or a purified chemical. 
Traditional herbal formulations could follow such 
regulatory guidance to create scientific evidence base with robust 
chemistry, manufacturing and controls. Department of Ayurveda, 
Yoga, Unani, Siddha, Homeopathy (AYUSH) in India has 
recently established a Research Center at the University of 
Mississippi, Oxford, MS, USA to facilitate scientific 
investigations on Indian herbal drugs. Such efforts should help 
improve quality assurance, enhancing the chance of regulatory 
approvals and improving the acceptance of botanical drug 
products and formulations. 
Thus, if safe and effective herbal formulations are 
developed in accordance with stringent regulatory guidelines on a 
par with any modern drug, we hope that the conventional 
disbelief against herbals may slowly wane. Issues related to the 
appropriateness of conventional biomedical and clinical models 
for evaluating efficacy of traditional medicine remain, however, 
very crucial. A holistic approach based on systems biology seems 
much more suited to study therapeutic efficacy and 
pharmacodynamics of traditional medicine-based drug 
development. It can also be argued that instead of randomized 
controlled trials, strategies of pragmatic clinical trials may be 




The use of herbal drugs for the prevention and treatment 
of various health ailments has been in practice from time 
immemorial. Many plants belonging to varied geography are 
being studied in large to identify the compounds of medicinal 
value. However, the researchers are still finding difficulties in 
characterizing the compounds from the pool of plant metabolites 
for a specific activity. The crude extracts of many plants are 
reported to have multi-beneficial effect on diseases and disorders. 
The relative efficiency of each compound and the possibilities of 
purifying them to homogeneity and developing a drug 
formulation is still beyond reach. Moreover, generally it is 
believed that the risk associated with herbal drugs is very less, 
but reports on serious reactions are indicating to the need for 
development of effective marker systems for isolation and 
identification of the individual components. Standards for herbal 
drugs are being developed worldwide but as yet there is no 
common consensus as to how these should be adopted. 
Standardization, stability and quality control for herbal drugs are 
feasible, but difficult to accomplish. Further, the regulation of 
these drugs is not uniform across countries. There are variations 
in the methods used across medicine systems and countries in 
achieving stability and quality control. The search for new 
molecules, nowadays, has taken a slightly different route where 
the science of ethnobotany and ethnopharmacology are being 
used as guide to lead the biotechnologist towards different 
sources and classes of compounds. With intense research on the 
herbal compounds from our huge natural wealth, the 
development of herbal medicine technology for every of our 
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